News and Comments

SAREPTA: What's Going On ?

  Tuesday, April 16, 2013

The requests Sarepta Therapeutics (SRPT) has gotten from the FDA represent a sign of FDA seriousness towards bringing the firm’s drug eteplirsen for Duchenne muscular dystrophy as soon as possible to the children suffering from the debilitating, fast deteriorating disease. The FDA did not wait for the firm to file for early approval, it rather asked Sarepta to bring in more data that would legitimize granting early approval of the first drug ever to claim treating the disabling disease at its root-origin. Investors who should have been optimistic about the FDA initiative sold their shares instead, causing them to lose around 10% of their value.  More...

ImmunoGen Offers New Hopes For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Difficult-To-Treat Cancers

  Friday, April 12, 2013

 More...

A Quick Response To ARIAD'S (ARIA) Conference Call

  Thursday, April 04, 2013

 More...


Recent Postings


Archive


Tags

NOVOCURE (NVCR) ImmunoGen (IMGN) Bristol-Myers Squibb (BMY) Revlimid (lenolidamide) CEMPRA (CEMP) Ocular Therapeutix (OCUL) Velcade (bortezomib) TOKAI (TKAOI) Benlysta (belimumab) Amgen (AMGN) Alnylam (ALNY) GlaxoSmithKline (GSK) Prolor Biotech (PBTH) AGOS (ARGS) NANTKWEST (NK) Sangamo (SGMO) SUNESIS PHARMACEUTICALS (SNSS) Endometrial Cancer Elan (ELN) Merck (MRK) IDERA (IDRA) Aimmune Therapeutics (AIMT) OSI (OSIP) Bellicum (BLCM) ABBVIE (ABBV) Multiple Myeloma Anadys (ANDS) Mirati Therapeutics (MRTX) NEKTAR (NKTR)) JOUNCE THERAPEUTICS (JNCE) Intermune (ITMN) Sanofi (SNY) Roche (ROCHE) Theravance (THRX) Human Genome Sciences (HGSI) Regeneron (REGN) Adaptimmune (ADAP) Spike Therapeutics (ONCE) AERIE PHARMACEUTICALS Herceptin SYNTA (SNTA) Biocryst (BCRX) Anacor (ANAC) Editas (EDIT) Illumina (ILMN) Seattle Genetics (SGEN) Micromet (MITI) Ridaforolimus Sarepta (SRPT) Sequenom (SQNM) Exelixis (EXEL) Alder Biopharmaceuticals (ALDR) INNOVIVA (INVA) PTC Therapeutics (PTCT) BIOMARIN (BMRN) Abbott Laboratories (ABT) Cytokinetics (CYTK) KITE (KITE) Prosensa (RNA) Intercept (ICPT) Galena (GALE) VANDA (VNDA) Sanofi-Aventis (SAN) JUNO (JUNO) ACADIA (ACAD) Vertex (VRTX) Vitae Pharmaceuticals (VTAE) Tysabri CRISPR Therapeutics (CRSP) Biogen Idec (BIIB) GUARDIAN HEALTH C4 Therapeutics Dynavax (DVAX) Dendreon (DNDN) Zerenex Jazz Pharmaceuticals (JAZZ) SERES THERAPEUTICS (MCRB) MODERNA Agenus (AGEN Auspex (ASPX) Advaxis (ADXS) ARGOS (ARGS) Ariad (ARIA) Ziofpharm (ZIOP) Human Longevity (HLI) Trastuzumab-DM1 AstraZeneca (AZN) Theravance Bio Pharma (TBPH) RenenxBio (RGNX) ZALTRAP™ Valeant Pharmaceuticals International (VRX) Xoma (XOMA) Idenix (IDIX) ISIS (ISIS) galapagos (GLPG) KERYX (KERX) HALOZYME (HALO) Ionis (IONS) Gilead (GILD) Pluristem (PSTI) Roche (RHHBY) PORTOLA (PTLA) Global Cell Therapeutics (GBT) CompuGen (CGEN) ADVENTRIX (ANX) Rapamune Genentech Telaprevir Onyx (ONXX) ARCA (ABIO) REGULUS (RGLS) Sanofi (SNA) Agenus (AGEN) Inovio (INO) Incyte (INCY) Array Pharmaceuticals (ARRY) Intrexon (XON)